Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

2.
3.

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K.

BMJ. 2011 Jan 25;344:d7901. doi: 10.1136/bmj.d7901.

4.

Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.

Örtqvist Å, Bennet R, Hamrin J, Rinder MR, Lindblad H, Öhd JN, Eriksson M.

Vaccine. 2015 May 21;33(22):2558-61. doi: 10.1016/j.vaccine.2015.04.011. Epub 2015 Apr 11.

PMID:
25869891
5.

Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study.

Bakken IJ, Aaberg KM, Ghaderi S, Gunnes N, Trogstad L, Magnus P, Håberg SE.

BMC Infect Dis. 2015 Nov 9;15:506. doi: 10.1186/s12879-015-1263-7.

6.

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.

Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, Shneerson J, Verity C.

BMJ. 2013 Feb 26;346:f794. doi: 10.1136/bmj.f794.

7.

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O.

BMC Infect Dis. 2012 May 31;12:127. doi: 10.1186/1471-2334-12-127.

8.

Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.

Ortqvist A, Bennet R, Rinder MR, Lindblad H, Eriksson M.

Vaccine. 2012 Aug 24;30(39):5699-702. doi: 10.1016/j.vaccine.2012.07.009. Epub 2012 Jul 20.

PMID:
22819987
9.

Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.

Stowe J, Andrews N, Bryan P, Seabroke S, Miller E.

Vaccine. 2011 Nov 28;29(51):9467-72. doi: 10.1016/j.vaccine.2011.10.029. Epub 2011 Oct 20.

PMID:
22019757
10.

Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series.

Cohet C, Haguinet F, Dos Santos G, Webb D, Logie J, Lc Ferreira G, Rosillon D, Shinde V.

BMJ Open. 2016 Jan 28;6(1):e009264. doi: 10.1136/bmjopen-2015-009264.

11.

Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.

Salles MJ, Sens YA, Malafronte P, Souza JF, Vilas Boas LS, Machado CM.

Transpl Infect Dis. 2012 Dec;14(6):564-74. doi: 10.1111/j.1399-3062.2012.00769.x. Epub 2012 Aug 13.

PMID:
22882692
12.

Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.

Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, Boucher FD, Skowronski DM.

Pediatrics. 2011 Nov;128(5):e1084-91. doi: 10.1542/peds.2010-3492. Epub 2011 Oct 10.

PMID:
21987710
13.

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M.

BMJ. 2011 Feb 3;342:c7297. doi: 10.1136/bmj.c7297.

14.

Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway.

Guzmán Herrador BR, Aavitsland P, Feiring B, Riise Bergsaker MA, Borgen K.

BMC Infect Dis. 2012 Mar 20;12:63. doi: 10.1186/1471-2334-12-63.

15.

Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.

Andrews N, Stowe J, Al-Shahi Salman R, Miller E.

Vaccine. 2011 Oct 19;29(45):7878-82. doi: 10.1016/j.vaccine.2011.08.069. Epub 2011 Aug 27.

PMID:
21875631
16.

Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity.

Langley JM, Reich D, Aggarwal N, Connor D, Lebel MH, Gupta A, Garfield H, Li P, Madan A, Vaughn DW.

Pediatr Infect Dis J. 2012 Aug;31(8):848-58. doi: 10.1097/INF.0b013e31825e6cd6.

PMID:
22801094
17.

Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.

Puleston RL, Bugg G, Hoschler K, Konje J, Thornton J, Stephenson I, Myles P, Enstone J, Augustine G, Davis Y, Zambon M, Nicholson KG, Nguyen-Van-Tam JS.

Health Technol Assess. 2010 Dec;14(55):1-82. doi: 10.3310/hta14550-01.

18.

Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.

Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A.

J Heart Lung Transplant. 2011 Jun;30(6):685-90. doi: 10.1016/j.healun.2011.01.707. Epub 2011 Mar 27. Erratum in: J Heart Lung Transplant. 2011 Oct;30(10):1206.

PMID:
21444211
19.

Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.

Dauvilliers Y, Arnulf I, Lecendreux M, Monaca Charley C, Franco P, Drouot X, d'Ortho MP, Launois S, Lignot S, Bourgin P, Nogues B, Rey M, Bayard S, Scholz S, Lavault S, Tubert-Bitter P, Saussier C, Pariente A; Narcoflu-VF study group..

Brain. 2013 Aug;136(Pt 8):2486-96. doi: 10.1093/brain/awt187.

PMID:
23884811
20.

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Dramé M, Gillard P, van der Most R, Van Mechelen M, Hanon E, Leroux-Roels G.

Vaccine. 2010 Jan 8;28(3):849-57. doi: 10.1016/j.vaccine.2009.10.017. Epub 2009 Oct 14.

PMID:
19835828

Supplemental Content

Support Center